In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...

NewsMedical speaks with CN Bio about the translatability between in vitro organ-on-a-chip (OOC) models, microphysiological ...

Entrada Therapeutics can plough on with the development of its Duchenne muscular dystrophy (DMD) therapy, ENTR-601-44, now ...

Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues through the use of its FLAIRE platform based on ...

Adial Pharmaceuticals (ADIL) announced a “positive” response from the U.S. FDA regarding its proposed in vitro bridging strategy for AD04. The ...

Now is the time to begin reformulating foods and beverages with natural dyes if companies want to comply with upcoming state and federal bans of select synthetic colors and additives - though ...

Initial feasibility study of its soluble, Ph neutral, fast acting granular or powder drug delivery system is complete ...

The Food and Drug Administration granted fast track designation to AUTX-703 for relapsed or refractory acute myelogenous ...

Sterotherapeutics, a leading biopharmaceutical company dedicated to advancing innovative therapies, is announcing the launch of a Phase 2 clinical trial for ST-002, a novel drug candidate for patients ...

Experts say that for decades, a legal loophole has allowed companies to include chemical additives that could be potentially ...

This is a developing story. If you are a dismissed or active federal worker with information to share, please reach out at ...

Drug development is an expensive and high-risk process. The median cost per approved drug can reach up to $2.8 billion, ...